相关实验视频
Updated: Sep 11, 2025

03:25
Simple Continuous Glucose Monitoring in Freely Moving Mice
Published on: February 24, 2023
6.0K
用葡萄糖挑战测试和持续葡萄糖监测对透析患者进行糖尿病查 - - DIGEST研究
L Depoorter1, Y Laghrib2,3, J W De Fijter2,3
1Department of Endocrinology-Diabetology-Metabolism, Antwerp University Hospital, Faculty of Health Sciences and Medicine.
Diabetes, obesity & metabolism
|August 14, 2025
概括
葡萄糖挑战测试 (GCT) 是一种更简单的透析患者失糖症查工具,可能减少对更繁的口服葡萄糖耐受性测试 (OGTT) 的需要. 这种方法为检测高风险人群中的葡萄糖代谢问题提供了切实可行的替代方案.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 内分泌学 在内分泌学.
- 临床诊断 临床诊断 临床诊断
背景情况:
- 接受透析的患者面临患上糖尿病的风险较高.
- 口服葡萄糖耐受性测试 (OGTT) 是诊断失糖症的标准,但对患者来说不方便.
- 这项研究评估了在透析患者中更简单的失糖血的查方法.
研究的目的:
- 为了比较葡萄糖挑战测试 (GCT) 和持续葡萄糖监测 (CGM) 与口服葡萄糖耐受性测试 (OGTT) 的诊断准确性,用于透析患者的失糖症查.
- 评估GCT作为这一群体查工具的可行性和实用性.
主要方法:
- 一个单一中心前性诊断队列研究,涉及透析的成年人,没有先前的糖尿病史或降血糖治疗.
- 参与者接受了50g-GCT,随后进行持续血糖监测 (CGM),然后在8-10天后进行75g-OGTT.
- 数据分析的重点是将GCT和CGM的诊断性能与OGTT进行比较.
主要成果:
- 在23名参与者中,有13名患有失糖症,血液透析 (HD) 患者的患病率更高.
- 患有失糖症的个体表现出更高的BMI和更长的透析年龄.
- 该GCT显示了85%的敏感性和70%的特异性对于失糖症,可能避免40%的OGTTs.
- 在CGM的5%时间超出狭窄范围 (TATR) 显示高灵敏度 (92%),但低特异性 (12%).
结论:
- 葡萄糖挑战测试 (GCT) 是一种实用且可行的替代方案,用于在透析患者中查失糖症.
- 虽然CGM的5%TATR指标显示了高灵敏度,但其低特异性限制了其作为独立查工具的实用性.
相关概念视频
Diabetes: Symptoms, Diagnosis, and Complications
692
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
692
Diabetes Mellitus: Type 2 and Gestational
2.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.9K
Diabetes: Management and Pharmacotherapy
374
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
374
Chronic Kidney Disease I: Introduction
67
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
67
Chronic Kidney Disease III: Interprofessional Care
80
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
80
Diabetes Mellitus: Overview and Type I Subtype
3.2K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.2K

